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Abstract: Menopause is often accompanied by visceral obesity. With the aim of exploring the 29 
consequences of ovarian failure on visceral fat, we evaluated the effects of ovariectomy and 30 
estrogen replacement on the proteome/phosphoproteome and on the fatty acids profile of the 31 
retroperitoneal adipose depot (RAT) of rats. Eighteen three months old female Wistar rats were 32 
either ovariectomized or sham-operated and fed with standard chow for three months. A sub-33 
group of ovariectomized rats received estradiol replacement. RAT samples were analyzed using 34 
data-independent acquisitions LC-MS/MS and pathway analysis was performed with the 35 
differentially expressed/phosphorylated proteins. RAT lipid profile was analyzed by gas 36 
chromatography. 37 
Ovariectomy induced high adiposity and insulin resistance and promoted alterations in 38 
protein expression and phosphorylation. Pathway analysis showed that 5 pathways were 39 
significantly affected by ovariectomy, namely metabolism of lipids (included fatty acid 40 
metabolism and mitochondrial fatty acid β-oxidation), fatty acyl-CoA biosynthesis, innate 41 
immune system (included neutrophil degranulation), metabolism of vitamins and cofactors, and 42 
integration of energy metabolism (included ChREBP activates metabolic gene expression). 43 
Lipid profile analysis showed increased palmitic and palmitoleic acids content. The analysis of 44 
the data indicated that ovariectomy favored lipogenesis while it impaired fatty acids oxidation, 45 
and induced a pro-inflammatory state in the visceral adipose tissue. These effects are consistent 46 
with the findings of high adiposity, hyperleptinemia, and impaired insulin sensitivity. The 47 
observed alterations were partially attenuated by estradiol replacement. The data point to a role 48 
of disrupted lipid metabolism in adipose tissue in the genesis of obesity after menopause.  49 
 50 
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1. Introduction 53 
 54 
The cessation of ovarian hormones production in menopause is often followed by 55 
increased body weight gain and adiposity, associated with obesity-related co-morbidities (11, 56 
28). In both humans and rodents, a role of estrogens in metabolic, immune, and inflammatory 57 
processes has been established, although the complexity by which these effects occur is not 58 
fully understood (20, 45). The lack of estrogens after menopause has been associated with a 59 
shift of fat distribution from subcutaneous to visceral, with impairment of the sensitivity to 60 
insulin and leptin, predisposition to diabetes and to anxiety and depressive disorders (5, 14, 23). 61 
In both humans and rats, the visceral (or abdominal) adipose tissue comprises mesenteric, 62 
retroperitoneal, perirenal, and gonadal depots. Additionally, humans have the omental depot 63 
(38). A depot-specificity of functions has been described for the adipose tissue, which may 64 
result from differences intrinsic to pre-adipocytes and to factors secreted by neighboring organs 65 
(62). During the development of obesity, the visceral adipose tissue suffers a higher degree of 66 
hypertrophy and macrophage infiltration than the subcutaneous depots, leading to a high 67 
production of inflammatory mediators that contribute substantially to the pathophysiology of 68 
obesity complications (40, 46). 69 
Several disruptions of the metabolism of visceral adipose tissue have been reported in 70 
ovariectomized rodent models. Increased conversion of cortisone to cortisol, due to increased 71 
expression of type 1 11β-hydroxysteroid dehydrogenase, has been found in visceral but not in 72 
subcutaneous adipose depots, contributing to fat redistribution (3). Decreased glutathione 73 
peroxidase activity and superoxide dismutase protein levels, indicating impairment of anti-74 
oxidant status, as well as low mRNA levels of the anti-inflammatory hormone adiponectin, 75 
have also been observed (1). 76 
Using a two-dimensional gel electrophoresis-based proteomic approach, a recent study 77 
described that ovariectomy affected proteins involved in intermediate metabolism, energy 78 
transduction, cell structure, and immune system, in the periovarian adipose tissue of rats (2). 79 
The use of a more sensitive and accurate proteomic technique could help unravel a more 80 




Moreover, the identification of changes in protein phosphorylation is of high relevance, as it 82 
plays a pivotal role in a multitude of cellular functions.  83 
Additionally, perturbations of visceral adipose tissue functions have been associated with 84 
its fatty acids composition in several conditions, such as diet-induced obesity and diabetes (6, 85 
63). However, data on the effects of obesity induced by the loss of ovarian hormones in visceral 86 
adipose tissue fatty acid composition are scarce. One study reported increased levels of short-87 
chain saturated fatty acids levels in the visceral fat of postmenopausal women (67). Further 88 
studies on the subject are necessary. 89 
Aiming at expanding our knowledge on the consequences of ovarian failure on visceral 90 
fat, the present study examined the effects of ovariectomy and of estrogen replacement on the 91 
proteome/phosphoproteome as well as on the fatty acid profile of the retroperitoneal fat of rats.  92 
 93 
2. Materials and Methods 94 
 95 
2.1 Experimental procedures  96 
 97 
The experiments were performed in accordance with the Committee in Research Ethics of 98 
the Universidade Federal de São Paulo (CEUA nº: 2172030315/ 2016), which follow the 99 
guidelines of the Conselho Nacional de Controle de Experimentação Animal (CONCEA). The 100 
present data is part of our previously published investigation in which we evaluated the effects 101 
of ovariectomy, aligned or not to high-fat diet feeding, on metabolic and behavior parameters 102 
of rats (5). Briefly, the female Wistar rats (twelve-week-old) were either ovariectomized (Ovx 103 
group, n=12) or sham operated (Sham group, n=6) under ketamine/xylazine anesthesia 104 
(66/33mg/kg, ip). A sub-set of Ovx animals received 17β-estradiol replacement (Ovx+E2 105 
group), via subcutaneous pellets (0.25 mg/pellet, 90-day release; Innovative Research of 106 
America, Sarasota, Florida, USA). The daily dose of estrogen released was 2.8 µg/day/90 days, 107 
yielding a daily dose range of 0.010 to 0.008 mg/Kg/day, considering the mean initial and final 108 
body weights during the 12 weeks of treatment. One dose of penicillin (60.000U. i.m.) and 109 




they received one ibuprofen dose per day for the 2 subsequent days. They were maintained 111 
under a 12h light/dark cycle (lights on at 6 am) and 23 ± 1°C temperature with food (2.87 112 
kcal/g, 15% of energy from fat, Nuvilab CR-1, Nuvital Nutrientes SA, Colombo, PR, Brazil) 113 
and water ad libitum for 12 weeks. Body weight and 24-h food mass intake were measured 114 
once a week. Feed efficiency was calculated as: (body weight gain / energy intake) x 100. 115 
Euthanasia was conducted under thiopental anesthesia (80mg/kg, ip) after a 24-h fasting.  116 
Trunk blood was collected and white fat pads (retroperitoneal, gonadal and mesenteric) were 117 
dissected, weighed, and frozen in liquid nitrogen. All tissue and serum samples were stored at -118 
80ºC. The uteri were weighed for confirmation of completeness of ovaries removal. 119 
 120 
2.2 Serum and tissue cytokines measurements 121 
 122 
Serum measurements and HOMA index were conducted as previously described (5). 123 
RAT content of TNF-α (sensitivity – 2.4 ng/mL; intra-assay precision- 4.98%; inter-assay 124 
precision- 9.44%) and IL-6 (sensitivity – 0.7 ng/mL; intra-assay precision- 3.96%; inter-assay 125 
precision- 8.64%) were also determined by Elisa (R&D Systems, Minneapolis, MN, USA).  126 
 127 
2.3 Retroperitoneal fat proteome and phosphoproteome analyses 128 
 129 
Aliquots (800 mg) of RAT fat pads were homogenized in 1mL of buffer containing 50 130 
mM ammonium bicarbonate, 1% sodium deoxycholate (m/v), and deionized water (51), with 131 
the addition of a protease/phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL, 132 
USA), and centrifuged at 19,000 x g for 30 minutes at 4oC. Protein concentration in the 133 
supernatants was determined using a Pierce BCA assay (Thermo Scientific, Rockford, IL, 134 
USA). Aliquots of 200 μg of protein were diluted in 50 mM ammonium bicarbonate to a final 135 
volume of 85 µL. Samples were then subjected to reduction with 2.5 μL of 100 mM DTT at 136 
60oC for 30 min and alkylation with 2.5 μL of 300 mM iodoacetamide, at room temperature for 137 
30 min. Proteins were digested overnight using trypsin (Promega, Fitchburg, WI, USA) at a 138 




19,000 x g for 15 minutes at 4ºC, the supernatants were collected and an equal volume of ethyl 140 
acetate was added (36). Then, trifluoroacetic acid was added to a final concentration of 0.5%. 141 
Samples were homogenized in vortex and centrifuged at 19,000 x g for 5 minutes at 4oC. 142 
Supernatants were collected, transferred to Millex-GV filters (Millipore, Burlington, MA, 143 
USA), recovered, dried in a vacuum concentrator centrifuge (Eppendorf, Hamburg, HH, 144 
Germany), and stored at -80oC until mass spectrometry analysis.  145 
 146 
2.4 Liquid-chromatography mass spectrometry  147 
 148 
After reconstitution of the samples in 1 % (v/v) formic acid, protein content was 149 
determined fluorimetricaly (Qubit® 3.0 Fluorometer, Thermo Scientific, Rockford, IL, USA) 150 
and the final concentration was adjusted to 0.5 µg/µL. The proteomic and phosphoproteomic 151 
analyses were performed by data-independent acquisitions liquid-chromatography mass 152 
spectrometry (ACQUITY UPLC M-Class coupled to Synapt G2-Si mass spectrometer) 153 
(Waters, Milford, MA, USA). An ACQUITY UPLC HSS T3 nanoACQUITY Column (100 Å. 154 
1.8 μm. 75 μm × 150 mm., Waters) was used for peptides separation (1µg) in acetonitrile 155 
gradient from 7% (v/v) for 54 min, and then increased to 80% of acetonitrile for 13 min, at a 156 
flow rate of 500 nL/min). Data were acquired using nanoESI ionization on positive mode, in 157 
HDMSE mode using Transfer MS Collision Energy Low (eV) 19.0 and Transfer MS Collision 158 
Energy High (eV) 53.0. Human Glu-fibrinopeptide B was used for mass spectrometer 159 
calibration. MS identification was made between 50 and 2000 m/z. 160 
 161 
2.5 Database search 162 
 163 
Mass spectrometry data processing and database search against Rattus norvegicus 164 
sequences (UniProtKB/Swiss-Prot database, www.uniprot.org, 8680 entries) were performed 165 
with the Progenesis for Proteomics software (version 4.0, Waters). Peptides identification 166 
followed the parameters: maximum 1 missed cleavage site allowed for trypsin digestion; 167 




modification. The search for phosphopeptides was made through variable modification of 169 
serine, threonine and tyrosine phosphorylation. Protein identification used the following 170 
criteria: False discovery rate (FDR) set at less than 1%, minimum of 2 fragment ions per 171 
peptide, 5 fragment ions per protein, and 2 peptides per protein. Relative protein quantification 172 
was performed by the Hi-N approach, using the three most abundant peptides, with priority of 173 
the unique peptides’ ones (58). Normalized data were exported to Excel files. 174 
 175 
2.6 Pathway analysis 176 
 177 
The proteins differentially expressed and/or differentially phosphorylated among the 178 
groups were included in the test to determine enriched pathways, using the online Panther 179 
platform (http://www.pantherdb.org, version 14.1, released 2019-07-11). The whole Rattus 180 
norvegicus proteome was used as the reference list and the Reactome Pathways was used as the 181 
annotation data set. Significantly enriched pathways were based on Fisher’s exact test followed 182 
by Bonferroni correction with significance set to p < 0.05. 183 
 184 
2.7 RAT fatty acid composition 185 
 186 
Aliquots of 1,000 mg of RAT were extracted in hexane/isopropanol (3:2 v/v) containing 187 
0.01% butylated hydroxytoluene (BHT). After addition of chloroform/methanol/water (2:1:1 188 
v/v/v), the samples were centrifuged (10,000 x g for 10 minutes) and the organic layers were 189 
separated and evaporated to complete dryness with oxygen-free nitrogen (OFN). The lipids 190 
were partitioned again in chloroform/methanol/water (8:4:3 v/v/v) and the chloroform layer 191 
was dried under OFN. 192 
Fatty acid analysis was performed as previously described (7). Briefly, fatty acid methyl 193 
esters (FAME) were obtained by heating the samples with 15% acyl chloride in dry methanol 194 
in a sealed tube at 70ºC during 3 hours under OFN. A solution of 5% NaCl was used to stop the 195 
reaction, at room temperature, and FAMEs were extracted by 3 washings with petroleum ether 196 




Shimadzu, Kyoto, Japan) was performed with a TRACE TR-FAME capillary column (Thermo 198 
Scientific, Rockford, IL, USA). The intensity of peaks was quantified using the software 199 
Labsolutions (Shimadzu, Kyoto, Japan). 200 
 201 
2.8 Statistical analysis 202 
 203 
Body weight, white fat depots mass, and serum parameters variables were tested for 204 
normality (Shapiro-Wilk test) and homoscedasticity (Levene’s test). Normally distributed 205 
variables (means ± standard error) were analyzed ANOVA and Tukey post hoc test. Non-206 
parametric variables (median and interquartile range) were analyzed by Kruskal-Wallis 207 
ANOVA followed by two tailed multiple comparisons. All tests were performed with Statistica 208 
12 Software (StatSoft, Tulsa, OK, USA) for p < 0.05. 209 
Proteome and phosphoproteome data were submitted to analysis on the online platform 210 
MetaboAnalyst (http://www.metaboanalyst.ca). Data were log transformed and the missing 211 
values were replaced by half the minimum positive value in the original data. The data was 212 
normalized by pareto scaling and submitted to principal component analysis (PCA) followed by 213 
partial least-squares discriminant analysis (PLSDA). Variable importance for the projection 214 
(VIP) values higher than 1.5 in the principal component 1 were considered in order to identify 215 
the proteins and phosphopeptides that most contributed to discrimination among the groups. 216 
 217 
3. Results 218 
 219 
3.1 Ovariectomy induced high adiposity and insulin resistance 220 
 221 
As shown in Table 1, the success of ovariectomy was confirmed by the low uterus weight 222 
of the ovariectomized groups. Initial body weight was similar among the 3 groups while both 223 
ovariectomized groups had higher body weights, feed efficiency and total fat mass at the end of 224 
the 12 weeks. Regarding the individual fat depots masses, while the gonadal fat depot was not 225 




ovariectomy and not normalized by estrogen replacement. The elevations induced by 227 
ovariectomy in leptin and insulin levels, leptin/adiponectin ratio, HOMA-IR and HOMA-β 228 
were significantly attenuated by estradiol replacement. Total cholesterol, HDL-cholesterol and 229 
triglycerides levels did not differ significantly among the groups. RAT levels of TNF-α and IL-230 
6 were similar among the groups. 231 
 232 
3.2 Ovariectomy induced changes in protein expression and phosphorylation and modified 233 
metabolic pathways in retroperitoneal fat 234 
 235 
Among the 18 biological samples, 13.722 peptides, corresponding to 1.246 proteins, were 236 
identified, of which 994 proteins met the inclusion criteria and were included in the statistical 237 
analysis. The multivariate analysis found 91 RAT proteins significantly modulated among the 238 
groups. The PLSDA analysis based on principal components showed a separation between the 239 
Sham and the Ovx groups while the Ovx+E2 group presented an intermediate profile (Figures 240 
1A). Forty-two proteins were downregulated and 49 proteins were upregulated by ovariectomy, 241 
in relation to the Sham group. The E2-replacement group presented 43 downregulated proteins 242 
and 48 upregulated proteins, in comparison to the Sham group. The complete list of proteins 243 
with altered expression is presented in Appendix 1 (supplementary material).   244 
Considering the phosphoproteome results, 1074 peptides were identified with at least one 245 
phosphorylation site, corresponding to 468 proteins. The multivariate analysis found 107 246 
peptides (corresponding to 96 proteins) with a characteristic phosphorylation pattern for each 247 
group. The analysis based on principal components showed a separation of Sham and Ovx 248 
groups, while the replacement group showed to be in an intermediate position (Figures 1B). In 249 
comparison to the Sham group, the Ovx group showed decreased phosphorylation of 39 250 
proteins and 68 proteins showed increased phosphorylation. The Ovx+E2 group showed 251 
downregulation of 42 proteins and 65 proteins with increased phosphorylation compared to 252 
Sham group. The complete list of proteins with altered phosphorylation is presented in 253 




 The pathway overrepresentation test showed significantly enrichment of pathways 255 
involved in lipid metabolism: fatty acyl-CoA biosynthesis pathway (1 protein/4 256 
phosphopeptides; p = 2.67E-2) (Figure 2A) and metabolism of lipids pathway (9 proteins/11 257 
phosphopeptides; p = 5.30E-5), the latter including fatty acid metabolism (6 proteins/9 258 
phosphopeptides; p = 7.35E-8) and mitochondrial fatty acid β-oxidation (4 proteins/2 259 
phosphopeptides; p = 1.65E-3) (Figure 2B). The proteins participating in these pathways 260 
included long-chain-fatty-acid-CoA ligase 5 (ACSL5), long-chain-fatty-acid-CoA ligase 1 261 
(ACSL1), short-chain specific acyl-CoA dehydrogenase (ACADS), long- chain specific acyl-262 
CoA dehydrogenase (ACADL), very long- chain specific acyl-CoA dehydrogenase 263 
(ACADVL), acyl-coenzyme A thioesterase type 2 (ACOT2), enoyl-CoA delta isomerase-1 264 
(ECI1), acetyl-CoA carboxylase-1 (ACC1), and fatty acid synthase (FAS) (Table 2). 265 
The innate immune metabolism pathway (10 proteins/16 phosphopeptides; p = 1.82E-7), 266 
including the neutrophil degranulation pathway (5 proteins/13 phosphopeptides; p = 2.07E-10), 267 
was also altered by ovariectomy (Figure 3), and the affected proteins included the platelet 268 
glycoprotein 4 (CD36). Two other important proteins related to the immune system were 269 
adenylyl cyclase-associated protein 1 (CAP1) and class I histocompatibility antigen, non-270 
RT1.A alpha-1 chain (RT1-AW2) (Table 2). 271 
The last two enriched pathways were the metabolism of vitamins and cofactors pathway 272 
(5 proteins/4 phosphopeptides; p = 4.29E-2) (Figure 4A) and the integration of energy 273 
metabolism pathway (3 proteins/6 phosphopeptides; p = 5.74E-4), which included the pathway 274 
ChREBP activates metabolic gene expression (3 phosphopeptides; p = 4.42E-2) (Figure 4B). 275 
Table 2 also shows that ovariectomy induced changes in two proteins related to 276 
adipogenesis, all-trans-retinol 13,14-reductase (RETSAT) and lipoprotein lipase (LPL) as well 277 
as two proteins involved in insulin sensitivity, elongation factor 1-delta (EEF1D) and integrin-278 
β1 (ITB1). 279 
 280 
3.3 Ovariectomy increased saturated fatty acid content and disturbed the polyunsaturated fatty 281 





The results regarding the fatty acid analyses are depicted in Table 3. The Ovx group 284 
showed increased content of lauric, myristic and palmitic acids in relation to Sham. Increased 285 
total saturated fatty acids (SFA), alongside increased palmitic/stearic ratio, was also found in 286 
Ovx group. Estrogen replacement brought the content of lauric and myristic acids, as well as 287 
total SFA, back to levels comparable to Sham. 288 
The monounsaturated fatty acids (MUFAs) myristoleic and palmitoleic acids levels were 289 
higher in Ovx group as compared to Sham, but comparable to Sham when estrogen 290 
replacement was introduced. Eicosenoic acid was lower in both Ovx and Ovx+E2 groups as 291 
compared to Sham. The palmitic/palmitoleic ratio was significantly decreased in Ovx, but 292 
normalized in Ovx+E2 group. 293 
Ovariectomy led to a significant disturbance in the proportions of various polyunsaturated 294 
fatty acids (PUFAs). The essential fatty acids alpha-linoleic and linoleic acids were 295 
respectively increased and decreased in the Ovx group, as compared to the Sham group. 296 
Estrogen replacement was successful in returning linoleic acid back to a level comparable to 297 
Sham, but the same was not found for alpha-linolenic acid. A significant increase in 298 
eicopentaenoic acid (EPA) was found in Ovx and Ovx+E2 groups. An increase in arachidonic 299 
acid (AA) was also found in both groups, as compared to the Sham group, but such difference 300 
did not reach statistically significant levels. 301 
Ovariectomy increased 0.33% of the total n-3 while decreasing 3% of the total n-6, in 302 
comparison to the Sham group. Such differences reached statistically significant levels, and 303 
whilst they remained for total n-3 in Ovx+E2 group, they were no longer statistically different 304 
for n-6 in Ovx+E2 group. The total n-6/n-3 ratio was lower in Ovx and Ovx+E2 groups, in 305 
comparison to the Sham group; however, the total SFA/PUFA ratio was higher in Ovx, and 306 
similar in Ovx+E2, when compared to Sham. 307 
 308 
4. Discussion 309 
 310 
Menopause has been considered as an important factor leading to obesity, mainly due to 311 




loss of ovarian hormones could lead to impairment of protein and lipid regulation in the 313 
visceral adipose tissue. In order to test this hypothesis, we used shotgun proteomics, along with 314 
fatty acid profiling, to determine proteins and lipids affected and to evaluate to what extent 315 
estrogen replacement would modify the ovariectomy-induced alterations. 316 
In the rat, the visceral adipose tissue is comprised by the retroperitoneal, perirenal, 317 
perigonadal, and mesenteric depots (38). Ovariectomy has been shown to induce significant 318 
changes in RAT metabolism (1, 12, 49). 319 
Ovariectomy increased body weight gain and adiposity due to increased feed efficiency, 320 
as food intake was not increased. Insulin and leptin levels, leptin/adiponectin ratio, and HOMA 321 
indexes also increased after ovariectomy and these alterations were attenuated by the estradiol 322 
replacement therapy, as we have previously shown (5). The estrogen replacement dose was 323 
chosen as to be compatible with the human dosage of the average transdermal replacement 324 
therapy for postmenopausal women (22, 48).  325 
The pathway analyses indicated that the ovariectomy had a large impact on the 326 
metabolism of lipids, affecting fatty acid metabolism/mitochondrial fatty-acids β–oxidation 327 
pathway and the fatty acyl-CoA biosynthesis pathway. Figure 5 depicts the main effects of 328 
ovariectomy in these pathways, which will be addressed below. 329 
The activation of free fatty acids by their association with coenzyme-A, yielding fatty-330 
acyl CoA, is promoted by the ligases enzymes and represents a crucial step both for β-oxidation 331 
and synthesis of triacylglycerols and other lipids. In comparison to the Sham group, we 332 
observed down regulation of the protein ACSL5, a feature that has been associated with low β-333 
oxidation rates (27), and increased phosphorylation of the protein (ACSL1). The present result 334 
on ACSL5 agrees with a previous report of its reduced gene expression in diabetic mice (32). 335 
The phosphorylation sites of the ACSL1 found in the present study (Thr27 and Thr40) have not 336 
been reported previously while a threonine phosphorylation site (Thr85) was described in liver 337 
mitochondria of normal rats under physiological conditions (13). 338 
The acyl-CoA dehydrogenases, responsible for fatty acyl-CoA desaturation in the β-339 
oxidation pathway (19), also showed an effect of ovariectomy. The protein ACADS showed 340 




white adipose tissue from obese subjects (39). The ACADL and ACADVL proteins presented 342 
increased phosphorylation (Ser210 and Ser418, respectively), as compared to the Sham group.  343 
While ACADVL has no phosphorylation sites previously reported, there is a previous 344 
description of decreased serine phosphorylation of ACADL (Ser28/Ser30) after ischemia in 345 
ovarian tumor grafts (41) and a demonstration that its decreased phosphorylation (Ser586) in 346 
fibrotic lung cells was associated with higher lipid peroxidation in comparison to normal lung 347 
cells (24).  348 
Two other enzymes of the mitochondrial fatty-acids β–oxidation pathway, ACOT2 and 349 
ECI1, showed downregulation in response to ovariectomy. Located in the mitochondrial 350 
matrix, ACOT2 targets mainly long-chain fatty acyl-CoAs and catalyzes their hydrolysis to the 351 
free fatty acids and CoA.  This mechanism has been proposed to enhance hepatic long-chain 352 
fatty acids oxidation by preventing accumulation of fatty acyl-CoA during high rates of hepatic 353 
β-oxidation (43, 61). ECI1 is involved in the process of oxidation of unsaturated fatty acids and 354 
has been reported to be downregulated in white adipose tissue from Zucker diabetic-fatty 355 
female rats (34).  356 
Ovariectomy also affected proteins involved in fatty acids synthesis. The protein ACC1 357 
showed decreased phosphorylation at Thr2278, attenuated by estradiol replacement. ACC1 358 
converts acetyl-CoA into malonyl-CoA during de novo lipogenesis. Although the 359 
phosphorylation site found in the present study has not been previously described, the 360 
phosphorylation of at least other five sites was demonstrated to inhibit the protein activity, 361 
resulting in lower malonyl-CoA levels (25, 18). In addition, the protein FAS showed increased 362 
phosphorylation at Ser725, in comparison to the Sham group. FAS is a key enzyme in the 363 
lipogenesis process, catalyzing the conversion of malonyl-CoA to palmitic acid (59). FAS 364 
phosphorylation at Ser725 was increased in the liver of mice after re-feeding, a situation 365 
favoring lipogenesis (65). Ovariectomy has been shown to increase FAS protein expression in 366 
the retroperitoneal adipose tissue of rats (31). The present observation that the lipid metabolism 367 
alterations induced by ovariectomy were attenuated by estradiol replacement agrees with a 368 




Ovariectomy also modulated proteins involved in the adipogenesis process. The protein 370 
RETSAT showed increased expression and decreased phosphorylation in comparison to the 371 
Sham group. This protein favors adipocyte differentiation under normal metabolic conditions 372 
and was shown to be induced during adipogenesis, being positively regulated by the 373 
transcription factor peroxisome proliferator activated receptor γ. Furthermore, the 374 
downregulation of the protein has been shown to inhibit adipogenesis (44, 57). Because the 375 
present Ovx animals showed increased body fat and mild increases in adipose tissue citokyne 376 
levels, it can be suggested that the upregulated RETSAT indicates a state of active fat 377 
accumulation. Moreover, further studies are necessary to elucidate the consequences of reduced 378 
phosphorylation of the sites found in the present study (Ser404/Tyr409). 379 
The protein LPL showed increased expression and phosphorylation in the Ovx groups, as 380 
compared to the Sham group, indicating a high capacity of the retroperitoneal adipose tissue for 381 
uptake of lipoprotein-derived free fatty acids. This enzyme has also been implicated in 382 
adipocyte differentiation and it has shown increased expression in adipose-derived 383 
mesenchymal stem cells from ovariectomized mice (17). Moreover, estrogens have been shown 384 
to decrease LPL expression in the subcutaneous fat of premenopausal women (52). Of note, we 385 
were not able to find previous records of the phosphorylation site found in the present study 386 
(Tyr191). 387 
Since ovariectomized animals were obese and showed alterations in many proteins 388 
involved in lipid metabolism, we hypothesized that fatty acid composition of RAT could be 389 
affected. Data about the effects of ovariectomy-induced obesity on fatty acid profile are scarce, 390 
although the pro-inflammatory state of common obesity has been associated to SFA in the 391 
adipose tissue (10). Our results showed an increased palmitic acid and total SFA contents of 392 
RAT. Estrogen replacement was able to attenuate these effects. In postmenopausal obese 393 
women, visceral adipose tissue inflammation has been related to accumulation of SFA, 394 
especially palmitic acid (66). Although palmitic acid has been shown to impact fatty acids 395 
metabolism by upregulating the expression of ACSLs (47, 53), high levels have been found to 396 




Ovariectomy also increased the percentage of the monounsaturated palmitoleic fatty acid. 398 
Endogenous non-dietary palmitoleic acid originates mainly from de novo lipogenesis in white 399 
adipose tissue, and has been recently considered as a lipokine, since it is released from the 400 
tissue and acts on distant cells. However, its metabolic effects have not been elucidated, as both 401 
deleterious and beneficial effects on adiposity, insulin sensitivity and lipid profile have been 402 
described (16). In the present study, its higher levels after ovariectomy are consistent with the 403 
proteomic results indicating a high lipogenesis rate, attenuated by estradiol replacement. 404 
Regarding polyunsaturated fatty acids, our results showed a decrease in linoleic acid (n-6) 405 
and an increase in alpha-linolenic acid (n-3). Linoleic acid is a precursor of pro-inflammatory 406 
lipid mediators such as prostaglandins and leukotrienes (54). Although we did not measure 407 
these factors, it is fair to speculate that the decrease in linoleic acid in the ovariectomized 408 
animals was a consequence of its recruitment for the production of pro-inflammatory factors, 409 
since we had indications of an inflamed status induced by ovariectomy, as discussed above. 410 
Given the fact that the sum of PUFAs did not differ among the groups, the increase in n-3 was a 411 
direct consequence of the n-6 decrease. 412 
These present findings indicate that ovariectomy favored a disruption of fat metabolism, 413 
which may have been relevant in the development of obesity. However, on the basis of our 414 
observations, it is not possible to rule out that, rather than a cause, the observed changes in lipid 415 
metabolism were a consequence of obesity.   416 
The pathway analysis also showed that several proteins that take part in the innate 417 
immune system, which orchestrates inflammation (15), were modulated by ovariectomy. CD36 418 
produced in macrophages is considered a pro-inflammatory marker. In the present study, this 419 
protein was upregulated by ovariectomy, in comparison to the Sham group, in agreement with 420 
findings in the visceral adipose tissue of postmenopausal women, obese individuals of both 421 
genres, and in the perivascular adipose tissue of diabetic rats (4, 30). CD36 is also involved in 422 
fatty acid translocation, thus influencing fat storage. Increased mRNA levels of CD36 in liver 423 
and visceral adipose tissue of ovariectomized mice has been associated with hepatic steatosis 424 




acid oxidation measured in muscle cells lines (55). These data agree with the present 426 
suggestion of impaired fatty acid oxidation in the visceral adipose tissue after ovariectomy. 427 
Although not shown in the pathway analysis, it is relevant to notice two other proteins 428 
altered by ovariectomy which have important inflammatory roles. The protein CAP1 showed 429 
increased expression and phosphorylation, in comparison to the Sham group. In monocytes, 430 
this protein was described to function as a receptor for adipocyte-derived resistin, which in turn 431 
regulates inflammation signaling, leading to the release of pro-inflammatory cytokines. Its 432 
expression was found to be increased in cells extracted from white adipose tissue of obese 433 
humans (9). The phosphorylation at Thr306/Ser307 identified in the present study were found to 434 
be increased in response to lipopolyssacharide-induced inflammation in macrophages (29), 435 
which corroborates the idea of an overall inflammatory status of our experimental model. 436 
Moreover, the protein RT1-AW2 also showed increased expression and phosphorylation in 437 
comparison to the Sham group. This protein is involved in immune response and was shown to 438 
be upregulated in the secretome of hepatocytes of rats treated with hepato-carcinogenenic 439 
substances, a condition also associated with a pro-inflammatory environment (64). The 440 
phosphorylation site described in the present study (Ser295) has not been described yet but the 441 
Ser354 phosphorylation was found to be increased in liver mitochondria from obese mice (26). 442 
Estrogen replacement attenuated the ovariectomy-induced changes regarding the proteins 443 
CD36, CAP1 and RT1-AW2. These results are compatible with the increase in leptin levels as 444 
well as a decrease in leptin/adiponectin ratio and suggest an overall effect of estrogen 445 
replacement in reducing the inflammation status. This is compatible with reports that estradiol 446 
may regulate cell recruitment to inflammatory sites and decrease the production of pro-447 
inflammatory cytokines, balancing the acute innate immune response (60). 448 
Regarding the glucose metabolism impairment mentioned above, two proteins that play a 449 
role in insulin resistance were shown to be modulated by ovariectomy. One of them is EEF1D, 450 
which is involved in the protein elongation steps during the synthesis of a variety of proteins, 451 
acting in the regulation of translation and transcription (56). Insulin stimulates the activity of 452 
this enzyme, mainly through phosphorylation processes in adipose tissue, as observed after in 453 




downregulated expression in the Ovx group, as compared to the Sham group, is compatible 455 
with our suggestion of insulin resistance after ovariectomy. The other protein is ITB1, which 456 
showed decreased expression and increased phosphorylation induced by ovariectomy, as 457 
compared to the Sham group. The protein is localized in the cell membrane and participates in 458 
the signaling between extracellular matrix and the intracellular environment, and dysfunctional 459 
integrins have been related to insulin resistance (35). In visceral fat pads isolated from chow-460 
fed rats, ITB1 potentiated the ability of insulin to enhance tyrosine phosphorylation of insulin 461 
receptor substrate 1 (21). Increased phosphorylation at Ser263 described in the present study has 462 
been previously found in breast cancer, but the consequences of this cancer-induced alteration 463 
on ITB1 function have not yet been explored (42). Since this modification appeared in the 464 
present study in an obese pathological condition, it may be not inferred whether it yielded a 465 
deleterious effect or, alternatively, whether it represented a counter-regulatory mechanism to 466 
insulin resistance.  467 
 468 
5. Conclusion 469 
The present results indicate that ovariectomy favored lipogenesis while it impaired fatty 470 
acids oxidation, and induced a pro-inflammatory state in the RAT. These effects are consistent 471 
with the findings of high adiposity, hyperleptinemia, and impaired insulin sensitivity. The 472 
observed alterations were partially attenuated by estradiol replacement. The data point to a role 473 
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Figure legends 684 
 685 
FIGURE 1: Separation of the groups using multivariate analyses of proteome data 686 
(A) - Supervised PLSDA analyses based on 994 protein intensities. The principal components 687 
explaining the separation are 1 and 4; Q2=0.7; R2=0.9. (B) - Supervised PLSDA analyses 688 
based on 1074 peptide intensities. The principal components explaining the separation are 1 689 
and 2; Q2= 0.6; R2= 0.9.  690 
 691 
FIGURE 2: Representation of the innate immune metabolism pathway significantly and 692 
their associated proteins and phosphopeptides 693 
Pathway enrichment analysis: Fisher’s exact test followed by Bonferroni correction. The 694 
colored bars indicate the proteins expression/phosphorylation peak intensities. All 6 samples in 695 
each experimental group were included in the analyses 696 
 697 
FIGURE 3: Representation of the fatty acyl-CoA biosynthesis (A) and metabolism of 698 
lipids (B) pathways and their associated proteins and phosphopeptides 699 
Pathway enrichment analysis: Fisher’s exact test followed by Bonferroni correction. The 700 
colored bars indicate the proteins expression/phosphorylation peak intensities. All 6 samples in 701 
each experimental group were included in the analyses 702 
 703 
FIGURE 4: Representation of the metabolism of vitamins and cofactors (A) and 704 
integration of energy metabolism (B) pathways and their associated proteins and 705 
phosphopeptides 706 
Pathway enrichment analysis: Fisher’s exact test followed by Bonferroni correction. The 707 
colored bars indicate the proteins expression/phosphorylation peak intensities. All 6 samples in 708 






FIGURE 5: Summary of the alterations in lipid metabolism induced by ovariectomy, as 712 
indicated by the proteome/phosphoproteome analysis 713 
Red triangles indicate reduced protein expression; Arrows followed by amino acid symbol 714 
indicate reduced (↓) or increased (↑) phosphorylation of the residue in the protein shown. 715 
ACSL5: Long-chain fatty acid-CoA ligase 5; ACSL1: Long-chain fatty acid-CoA ligase 1; 716 
ACADS: Short-chain specific acyl-CoA dehydrogenase; ACADL: Long-chain specific acyl-717 
CoA dehydrogenase; ACADVL: Very long-chain specific acyl-CoA dehydrogenase; ACOT2: 718 
Acyl-Coenzyme A thiosterase typ2; ECI1: Enoyl-CoA delta isomerase-1; ACC1: Acetyl-CoA 719 









Table 1: Body and serum parameters 
 Sham  Ovx Ovx+E2 
Initial body weight (g) 264.79 ± 5.22  263.00 ± 3.79 263.51 ± 5.02 
Final body weight (g) 280.84 (272.38 - 285.75)  338.00 (336.00 - 339.50)* 335.71 (325.89 - 337.00)* 
Cumulative food intake (Kcal) 526.36 ± 14.87  570.90 ± 12.48 613.63 ± 13.01* 
      Feed efficiency (g/Kcal) 2.72 ± 0.54  13.52 ± 0.66* 11.98 ± 0.81* 
Uterus (g) 0.43 ± 0.03  0.11 ± 0.02* 0.15 ± 0.02* 
Total fat mass (g) 10.37 ± 0.89  17.71 ± 1.22* 15.89 ± 1.11* 
Retroperitoneal fat mass (g) 3.49 ± 0.30  7.23 ± 0.56* 6.02 ± 0.46* 
Mesenteric fat mass (g) 1.67 ± 0.17  3.75 ± 1.20* 3.38 ± 0.80* 
Periovarian fat mass (g) 4.97 ± 0.44  6.15 ± 0.48 5.98 ± 0.49 
Leptin (ng/mL) 2.17 (1.84 - 2.61)  10.06 (7.80-012.52)*# 5.97 (4.45 - 9.89) 
Adiponectin (µg/mL) 5.65 ± 0.59  8.06 ± 1.04 7.67 ± 0.91 
Leptin/Adiponectin 0.41 ± 0.06  1.42 ± 0.29*# 0.89 ± 0.18 
TNF-α (pg/mg of protein)  7.04 ± 0.72  7.45 ± 0.78  6.96 ± 2.34 
IL-6 (pg/mg of protein) 32.2 ± 5.28  54.6 ± 17.3  26.8 ± 2.62 
Glucose (mg/dL) 92.80 ± 2.98  105.72 ± 6.38 103.88 ± 6.29 
Insulin (ng/mL) 0.56 ± 0.06  2.32 ± 0.20*# 1.31 ± 0.12* 
HOMA-IR 3.18 (2.32 - 4.25)  14.37 (12.08 - 19.07)*# 7.93 (6.26 - 8.28) 
HOMA-β 0.18 (0.14 - 0.23)  0.52 (0.38 - 0.72)*# 0.29 (0.24 - 0.45) 
Total cholesterol (mg/dL) 115.46 (104.96 - 121.76)  140.84 (119.08 - 193.13) 126.34 (119.85 - 133.97) 
HDL cholesterol (mg/dL) 205.73 (179.01 - 251.91)  163.17 (146.18 - 174.05) 142.37 (135.50 - 157.63) 
Triglycerides (mg/dL) 99.18 (94.67 - 108.20)  111.27 (105.33 - 118.85) 122.54 (107.79 - 220.49) 
Data presented as mean ± SEM for variables with normal distribution or median-interquartile range (Q1-Q3) 
for variables not normally distributed. n=6 animals per group. * p < 0.05 vs Sham; # p < 0.05 vs Ovx+E2. 
Table 2: Highlighted proteins with altered expression and/or phosphorylation 
Protein (Phosphosite) 
Expression fold-change Phosphorylation fold-change 
Ovx/Sham Ovx+E2/Sham Ovx+E2/Ovx Ovx/Sham Ovx+E2/Sham Ovx+E2/Ovx 
Long-chain-fatty-acid-CoA ligase 5 0.61 0.72 1.18    
Long-chain-fatty-acid-CoA ligase 1 (Thr27/Thr40)    3.79 2.26 0.60 
Short-chain specific acyl-CoA dehydrogenase, mitochondrial 0.59 0.63 1.06    
Long-chain specific acyl-CoA dehydrogenase, mitochondrial (Ser210)    27.25 7.84 0.29 
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (Ser418)    4.49 1.75 0.39 
Acyl-coenzyme A thioesterase 2, mitochondrial 0.62 0.70 1.13    
Enoyl-CoA delta isomerase 1, mitochondrial 0.54 0.56 1.03    
Acetyl-CoA carboxylase (Thr2278)    0.12 0.84 7.21 
Fatty acid synthase (Ser725)    2.82 1.95 0.69 
All-trans-retinol 13,14-reductase (Ser404/Tyr409) 1.75 1.52 0.87 0.96 2.95 3.08 
Lipoprotein lipase (Tyr191) 2.15 2.03 0.94 1.78 1.04 0.58 
Platelet glycoprotein 4 1.53 1.33 0.86    
Adenylyl cyclase-associated protein 1 (Ser300/Thr306/Ser307) 2.12 1.01 0.47 18.49 1.20 0.07 
Class I histocompatibility antigen, Non-RT1.A alpha-1 chain (Ser295) 12.80 2.61 0.20 12.79 2.35 0.18 
Elongation factor 1-delta (Ser447) 0.65 0.76 1.18 0.23 0.34 1.52 
Integrin beta-1 (Ser263) 0.42 0.57 0.82 2.23 2.27 1.02 
 
Table 3. Fatty acid composition of RAT total lipid 
Fatty acid % of total fatty acids 
  Sham Ovx Ovx+E2 
C12:0 Lauric acid 0.04 ± 0.01 0.05 ± 0.01*# 0.04 ± 0.01 
C14:0 Myristic acid 0.62 ± 0.06 0.75 ± 0.07*# 0.67 ± 0.11 
C16:0 Pamitic acid 18.7 ± 1.4 21.2 ± 1.4* 20.4 ± 1.2* 
C18:0 Stearic acid 3.35 ± 0.21 3.21 ± 0.37 3.2 ± 0.15 
C20:0 Arachidinic acid 0.06 ± 0.01 0.04 ± 0.01* 0.05 ± 0.01* 
C22:0 Behenic acid 0.018 ± 0.001 0.009 ± 0.001*# 0.012 ± 0.001* 
C16:0/C18:0  5.75 ± 0.39 6.67 ± 0.88* 6.3 ± 0.57 
∑ SFA  22.8 ± 1.5 25.3 ± 1.5*# 24.4 ± 1.3 
C14:1n-7 Myristoleic acid 0.02 ± 0.01 0.03 ± 0.01*# 0.02 ± 0.01 
C16:1n-7 Palmitoleic acid 1.55 ± 0.3 2.36 ± 0.59*# 1.8 ± 0.52 
C18:1n-9 Oleic acid 27.7 ± 1.2 27.5 ± 1.7 27.2 ± 0.9 
C18:1n7 cis-vaccenic acid 2.32 ± 0.18 2.23 ± 0.12 2.31 ± 0.17 
C20:1n9 Eicosenoic acid 0.18 ± 0.02 0.15 ± 0.01* 0.16 ± 0.01* 
C18/C18:1  0.11 ± 0.01 0.11 ± 0.02 0.11 ± 0.01 
C16:0/C16:1n-7  12.2 ± 1.7 9.38 ± 1.8*# 12.3 ± 2.9 
∑ MUFA  31.8 ± 1.3 32.4 ± 2.3 31.4 ± 1.4 
C18:3n-3 Alpha-linolenic acid 1.50 ± 0.18 1.81 ± 0.14* 1.84 ± 0.05* 
C20:5n-3 Eicosapentaenoic acid (EPA) 0.02 ± 0.01 0.03 ± 0.001* 0.03 ± 0.01* 
C22:5n-3 Docosapentaenoic acid (DPA) 0.09 ± 0.02 0.09 ± 0.02 0.09 ± 0.02 
C22:6n-3 Docosahexaenoic acid (DHA) 0.16 ± 0.05 0.15 ± 0.06 0.15 ± 0.03 
∑ n-3  1.75 ± 0.28 2.08 ± 0.17* 2.11 ± 0.08* 
C18:2n-6 Linoleic acid 40.14 ± 2.0 37.1 ± 2.8* 38.5 ± 2.3 
C18:3n-6 Gamma-linoleic acid 0.07 ± 0.02 0.1 ± 0.01* 0.09 ± 0.02* 
C20:2n-6 Eicosadienoic acid (EDA) 0.19 ± 0.02 0.16 ± 0.03* 0.17 ± 0.2* 
C20:3n-6 Dihomo-gamma linoleic acid 0.14 ± 0.02 0.14 ± 0.02 0.15 ± 0.01 
C20:4n-6 Arachidonic acid (AA) 0.63 ± 0.17 0.69 ± 0.18 0.74 ± 0.14 
C22:4n-6 Docosatetraenoic acid 0.23 ± 0.08 0.19 ± 0.06 0.20 ± 0.04 
∑ n-6  41.4 ± 2.2 38.4 ± 3.0*# 39.9 ± 2.4 
∑ n-6/ ∑ n-3  24.1 ± 3.9 18.5 ± 0.7* 18.9 ± 0.9* 
∑ PUFA  43.1 ± 2.4 40.5 ± 3.2 42.1 ± 2.5 
∑ SFA/ ∑ PUFA  0.53 ± 0.07 0.63 ± 0.08* 0.58 ± 0.06 
Data presented as means ± SEM of the % of total FAs. n=6 for each group. SFA: saturated fatty acids; 
MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; t: trans fatty acids. *p < 0.05 vs 
Sham; #p < 0.05 Ovx vs Ovx+E2 
